現在価格
目標株価
アナリスト評価
7 評価: 買い
Cybin Inc. is a biotechnology company focused on psychedelic-based therapeutics, aiming to enhance mental health treatment with innovative drug development. The company is leveraging its proprietary platforms to develop...|
e.g. Promoter holding
Loading chart...
アナリストによるEPSおよび売上高の予想コンセンサス。
| Metric (B) | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | FY 2027 |
|---|---|---|---|---|---|---|
| $-0.30 | $-0.22 | $-0.26 | $-3.19 | $-4.29 | $-4.03 | |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| +3.2% | +0.0% | +0.0% | +17.1% | -0.4% | +16.4% |
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | RRezolute I... | RZLT | $353.54M | — | 4.11 | — | — | -66.80% | — |
| 2. | PPepGen Inc | PEPG | $410.98M | — | 2.93 | — | — | -55.10% | — |
| 3. | RRelmada Th... | RLMD | $449.19M | — | 2.18 | — | — | -64.70% | — |
| 4. | NNeoleukin... | NGNE | $495.37M | — | 1.40 | — | — | -38.40% | — |
| 5. | SShattuck L... | STTK | $473.57M | — | 2.45 | — | — | -47.20% | -66.60% |
連結数値(百万円)/単体表示可
| Quarter (M) | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 |
|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COGS | 0.14 | 0.14 | 0.14 | 0 | 0 | 0 | 0 | 0 |
Gross Profit | -0.14 | -0.14 | -0.14 | 0 | 0 | 0 | 0 | 0 |
Gross Profit % | - | - | - | - | - | - | - | - |
| 26.88 | 25.2 | 20.32 | 58.25 | 31.3 | 33.27 | 24.62 | 28.89 | |
EBIT | -27.02 | -25.2 | -20.32 | -58.25 | -31.3 | -33.27 | -24.62 | -28.89 |
OPM % | - | - | - | - | - | - | - | - |
Non-Operating Income | -3.31 | 3.85 | 5.49 | 1.06 | 20.76 | 2.69 | 0.01 | -4.83 |
PBT | -30.33 | -21.35 | -14.82 | -57.19 | -10.54 | -30.58 | -24.61 | -33.72 |
Income Tax | 0.18 | -3.85 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Rate % | -0.6% | 18.03% | - | - | - | - | - | - |
Net Income | -30.33 | -21.35 | -14.82 | -57.19 | -10.54 | -30.58 | -24.61 | -33.72 |
NPM % | - | - | - | - | - | - | - | - |
連結数値(百万円)/単体表示可
| Period (M) | Dec 2017 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0.86 | 0 | 0 | 0 | 0 |
COGS | 0 | 0 | 0 | 0.66 | 0.17 | 0.25 | 0.42 | 0 |
Gross Profit | 0 | 0 | 0 | 0.2 | -0.17 | -0.25 | -0.42 | 0 |
Gross Profit % | - | - | - | 23.15% | - | - | - | - |
| 0.13 | 0.08 | 1.94 | 30.72 | 63.84 | 51.52 | 78.84 | 143.15 | |
EBIT | -0.13 | -0.08 | -1.95 | -31.04 | -63.84 | -51.52 | -78.84 | -143.15 |
OPM % | - | - | - | -3592.01% | - | - | - | - |
Non-Operating Income | 0 | 0 | 0 | -1.19 | -3.79 | 4.03 | 0.76 | 30.01 |
PBT | -0.13 | -0.1 | -1.94 | -32.22 | -67.63 | -47.49 | -78.08 | -113.14 |
Income Tax | 0 | -0.16 | 0 | 0.01 | 3.79 | -7.45 | 0 | 0 |
Tax Rate % | - | 159.41% | 0% | -0.03% | -5.61% | 15.69% | - | - |
Net Income | -0.13 | -0.1 | -1.94 | -32.22 | -71.42 | -40.04 | -78.08 | -113.14 |
NPM % | - | - | - | -3729.17% | - | - | - | - |
連結数値(百万円)/単体表示可
| Period (M) | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0.43 | 0.43 | 0.31 | 1.54 | 1.54 | 64.03 | 53.64 | 208.99 | 135.02 | |
| 0 | 0 | 0 | 0.07 | 0 | 0.24 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0.56 | 0.49 | 0.45 | 0 | 0 | |
| 0 | 0 | 0 | 0.1 | 2.46 | 4.5 | 7.82 | 5.07 | 30.95 | |
| 0.01 | 0.02 | 0.09 | 0 | -2.85 | 22.85 | 22.15 | 87.96 | 92.65 | |
Total Assets | 0.44 | 0.46 | 0.41 | 1.71 | 1.71 | 92.11 | 84.06 | 302.02 | 258.62 |
| 0.42 | 0.67 | 0.72 | 2.19 | 2.19 | 100.68 | 141.45 | 443.88 | 464.36 | |
| -0.13 | -0.23 | -0.33 | -0.74 | -0.74 | -14.56 | -65.3 | -151.95 | -227.16 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.29 | 0 | |
| 0.15 | 0.02 | 0.01 | 2.37 | 4.9 | 4.9 | 7.91 | 10.1 | 21.42 | |
| 0 | 0 | 0 | -2.11 | -4.64 | 1.09 | 0 | -0.29 | 0 | |
Total Liabilities | 0.44 | 0.46 | 0.41 | 1.71 | 1.71 | 92.11 | 84.06 | 302.02 | 258.62 |
連結数値(百万円)/単体表示可
| Period (M) | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | -0.24 | -0.08 | -0 | -19.03 | -19.03 | -45.21 | -68.91 | -101.3 | |
| -0.01 | -0.01 | -0.04 | -0 | -1.19 | -1.19 | -0.77 | 6.92 | -1.97 | |
| 0.44 | 0.25 | 0 | 0.01 | 82.72 | 35.78 | 35.78 | 254.51 | 20.2 | |
Net CFNet Cash Flow | 0.43 | 0 | -0.12 | 0 | 62.51 | 15.56 | -10.2 | 192.52 | -83.07 |
FCFFree Cash Flow | -0.01 | -0.25 | -0.12 | -0.14 | -19.26 | -19.26 | -45.73 | -69.62 | -103.27 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| - | - | -24.2% | -211.0% | -2225.1% | -163.1% | -49.3% | -42.4% | -42.8% | |
| - | - | - | - | - | - | - | 0.00 | - | |
| 2.88 | 27.38 | 23.32 | 6.24 | 6.24 | 13.57 | 7.38 | 21.65 | 7.75 | |
| - | - | - | - | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Conversion | -0.02 | - | 0.83 | 0.00 | 0.59 | 0.27 | 1.13 | 0.88 | 0.90 |
Payout Ratio | - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | -100.0% | - | - | - | |
| - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | - | |
| 4.00 | - | 2.00 | 2.00 | 3.00 | 4.00 | 2.00 | 4.00 | 2.00 | |
| - | - | - | - | - | - | - | - | - | |
| 0.00 | - | 0.00 | 0.00 | 20.00 | 0.00 | 0.00 | 50.00 | 0.00 | |
| - | - | - | - | -37.3% | - | - | - | - |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Cybin Incの株主構成(SEC提出書類より)
Schedule 13D / 13G filers (5%+), plus stakes Cybin Inc holds in others · open a holder to see each filing
| Holder | Type | Based in | Shares | % of class | Latest filing |
|---|---|---|---|---|---|
| Partnership | DE | 5,111,412 | 9.90% | SC 13G · 7 Nov 2025 | |
| Investment adviser | DE | 5,479,250 | 7.48% | SC 13G/A · 12 Nov 2026 | |
| Other | DE | 1,018,972 | 1.40% | SC 13G/A · 12 Nov 2026 | |
| Investment adviser | DE | 3,029,500 | 4.80% | SC 13G/A · 14 Aug 2026 | |
| Partnership | DE | 686,669 | 1.40% | SC 13G/A · 15 May 2026 | |
| Investment adviser | DE | 2,422,600 | 4.90% | SC 13G · 17 Feb 2026 | |
| Other | DE | 0 | 0.00% | SC 13G/A · 17 Feb 2026 | |
| Investment adviser | DE | 2,391,505 | 4.74% | SC 13G/A · 13 Feb 2026 | |
| Investment adviser | DE | 0 | 0.00% | SC 13G/A · 14 Feb 2025 |
Anyone owning more than 5% must file a Schedule 13D (active) or 13G (passive). Structured filings since December 2024; a holder that drops below 5% files an exit amendment. 13F still covers them in the shareholding table.
| Month | Insiders | Shares sold | Value sold | Shares bought | Value bought | Awards, tax, gifts |
|---|---|---|---|---|---|---|
| 4 | — | — | 698,000 | $8.6M | 496,000 | |
| 1 | — | — | 90,000 | $1.0M | — |
Form 4, filed within two business days of each trade. Sales and purchases are open-market; awards, tax withholding, gifts and option exercises are grouped. Amended filings are left out so a restated trade isn't counted twice.
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 31 Dec 2025 | 2,791,296 | +14.9% | 2.55 | |
| 15 Dec 2025 | 2,428,271 | +12.0% | 3.39 | |
| 28 Nov 2025 | 2,168,206 | -2.6% | 3.99 | |
| 14 Nov 2025 | 2,225,719 | +13.4% | 2.41 | |
| 31 Oct 2025 | 1,963,061 | -10.6% | 1.57 | |
| 15 Oct 2025 | 2,196,828 | -37.2% | 3.06 | |
| 30 Sep 2025 | 3,499,090 | +9.4% | 5.25 | |
| 15 Sep 2025 | 3,199,421 | +24.8% | 3.88 | |
| 29 Aug 2025 | 2,563,966 | -7.5% | 5.82 | |
| 15 Aug 2025 | 2,773,239 | +7.5% | 8.95 | |
| 31 Jul 2025 | 2,579,819 | +18.5% | 5.47 | |
| 15 Jul 2025 | 2,176,343 | +59.2% | 4.06 | |
| 30 Jun 2025 | 1,367,227 | +19.8% | 5.36 | |
| 13 Jun 2025 | 1,141,538 | +9.2% | 3.61 | |
| 30 May 2025 | 1,045,156 | -2.7% | 2.20 | |
| 15 May 2025 | 1,074,278 | -3.9% | 5.92 | |
| 30 Apr 2025 | 1,117,666 | -4.0% | 4.86 | |
| 15 Apr 2025 | 1,164,515 | +4.7% | 3.12 | |
| 31 Mar 2025 | 1,111,806 | +3.9% | 7.28 | |
| 14 Mar 2025 | 1,070,568 | -1.8% | 5.30 | |
| 28 Feb 2025 | 1,090,476 | +30.6% | 2.79 | |
| 14 Feb 2025 | 835,208 | -18.2% | 1.83 | |
| 31 Jan 2025 | 1,020,580 | +42.4% | 5.34 | |
| 15 Jan 2025 | 716,829 | +26.9% | 3.54 |
FINRA consolidated short interest, reported twice a month for every US listing.
Cybin IncのSEC提出書類と決算説明会の議事録
What recent news says about Cybin Inc, scored for sentiment.